Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

But Who’s Counting? Icahn Wins A Biogen Seat, Another Is “Too Close To Call”

Executive Summary

After a drama-packed shareholder meeting on June 3, Carl Icahn claims he won two of four contested seats on the 13-person, Biogen Idec board

You may also be interested in...



Agreement Averts Another Proxy Fight Between Biogen Idec, Icahn

Despite agreeing to support Biogen's nominee slate, Icahn says he still will push for biotech sale.

Agreement Averts Another Proxy Fight Between Biogen Idec, Icahn

Despite agreeing to support Biogen's nominee slate, Icahn says he still will push for biotech sale.

Court Date for Biogen and Elan Set for Sept. 3

The partners, who are litigating over Tysabri, face off earlier than expected.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel